Skip to main content
Caplight Logo









Viscient Bio Inc

Viscient Bio Inc

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://www.viscientbiosciences.com/

Last Round

Convertible Debt

Sep 15, 2021

Total Funding Raised

$1M

Company Overview

Viscient Bio Inc is a biotechnology company that develops novel therapies for liver diseases using proprietary 3D human tissue models.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

3D bioprintinghuman tissue modelsdrug discoveryin vitro modelingorgan-on-a-chipdisease modelingpreclinical researchMASHNASHphenotypic analysistherapeutic developmentanimal-free testingbiotech servicestarget validationnew approach methodologiesNAMs

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Viscient Bio Inc Comparables

Compare Viscient Bio Inc with similar companies based on industry and business-model similarity.

Viscient Bio Inc comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
VivoSim Labs, Inc.
82%
VoxCell BioInnovation
81%
InSphero
80%

Viscient Bio Inc Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Convertible DebtSep 15, 2021
Convertible DebtMay 30, 2019

Key People

Founding team and executive leadership

Jeffrey N Miner

Co-Founder And Chief Scientific Officer

Founding Team

Keith Murphy

CEO And Founder

Founding Team

Viscient Bio Inc Investors

Notable investors and investment history

Viscient Bio Inc investors
InvestorRounds
SternAegis VenturesConvertible Debt
Thynk CapitalConvertible Debt
Harmonix FundConvertible Debt
Methuselah FoundationConvertible Debt

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 30, 2019

    Harmonix Fund, methuselahfund, and Thynk Capital participated.

Viscient Bio Inc Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Viscient Bio Inc Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Viscient Bio Inc's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Diego, California
Employee Range7
Year Founded2017
Last FundingSep 15, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?